FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)
Practicing doctors share their perspectives on the use of HRT for menopausal women and the FDA's action to remove boxed warnings.
▶︎
FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women
▶︎
FDA Direct: What's the Deal with Talc? - Recapping
▶︎
FDA Direct: The Power of Real-Time Clinical Trials
▶︎
Understanding the Nutrition Facts Label, the Updated “Healthy” Claim, and Other Nutrition Claims
▶︎
FDA Direct: Catching Up on Agency Reforms
▶︎
Ebola Survivor - Dr. Ian Crozier
▶︎
FDA Expert Panel on Testosterone Replacement Therapy for Men
▶︎
FDA Direct: From Menopause to Food Safety: FDA's Latest Regulatory Priorities
▶︎
FDA Direct - Special Edition of FDA Direct
▶︎
FDA Direct: Combating Rare Diseases at the FDA
▶︎
FDA Direct: Priorities for a New FDA
▶︎
Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy
▶︎
FDA Direct: Who Buys the Spin — Hook, Line and Sinker?
▶︎
FDA Direct: An Eye on CDRH: Regulating for a New Era of Medical Devices
▶︎
Advancing Real-Time Clinical Trials
▶︎
FDA Direct: FDA is Not Your Doctor - Discussing FDA's Role and Mandate
▶︎
Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing
▶︎
OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products
▶︎
ClinicalTrials.gov: Essentials for Academic Medical Centers – Pre-recorded Training Video
▶︎